Osteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection

Annals of Thoracic Surgery

Volumn 96, Issue 6, 2013, Pages 1943-1951

  Sun, Bing Sheng ^a   Li, Yue ^a   Zhang, Zhen Fa ^a   You, Jian ^a   Wang, Chang Li ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD44V6 ANTIGEN; OSTEOPONTIN; HERMES ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION; CHINA; COMPARATIVE STUDY; EPIDEMIOLOGY; FOLLOW UP; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; MORTALITY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TRENDS;

ADULT; AGED; ANTIGENS, CD44; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION; CHINA; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; OSTEOPONTIN; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84889252021     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2013.07.089     Document Type: Article

References (29)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. C.F. Mountain Revisions in the International System for Staging Lung Cancer Chest 111 1997 1710 1717
3. P. Goldstraw, J. Crowley, and K. Chansky The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours J Thorac Oncol 2 2007 706 714
4. P.C. Hoffman, A.M. Mauer, and E.E. Vokes Lung cancer Lancet 355 2000 479 485
5. D.T. Denhardt, M. Noda, and A.W. O'Regan Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival J Clin Invest 107 2001 1055 1061
6. H. Rangaswami, A. Bulbule, and G.C. Kundu Osteopontin: role in cell signaling and cancer progression Trends Cell Biol 16 2006 79 87
7. B.S. Sun, Q.Z. Dong, and Q.H. Ye Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma Hepatology 48 2008 1834 1842
8. P.Y. Wai, and P.C. Kuo The role of Osteopontin in tumor metastasis J Surg Res 121 2004 228 241
9. H. Ponta, L. Sherman, and P.A. Herrlich CD44: from adhesion molecules to signalling regulators Nat Rev Mol Cell Biol 4 2003 33 45
10. K. Asosingh, U. Gunthert, and M.H. Bakkus In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells Cancer Res 60 2000 3096 3104
11. Y.U. Katagiri, J. Sleeman, and H. Fujii CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis Cancer Res 59 1999 219 226
12. I. Zlobec, U. Gunthert, and L. Tornillo Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer Histopathology 55 2009 564 575
13. S. Staibano, F. Merolla, and D. Testa OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome Br J Cancer 97 2007 1545 1551
14. G.H. Yang, J. Fan, and Y. Xu Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection Oncologist 13 2008 1155 1165
15. T. Hirata, T. Fukuse, and H. Naiki Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor Cancer Res 58 1998 1108 1110
16. J. Zhang, K. Takahashi, and F. Takahashi Differential osteopontin expression in lung cancer Cancer Lett 171 2001 215 222
17. L.R. Rodrigues, J.A. Teixeira, and F.L. Schmitt The role of osteopontin in tumor progression and metastasis in breast cancer Cancer Epidemiol Biomarkers Prev 16 2007 1087 1097
18. A.F. Chambers, S.M. Wilson, and N. Kerkvliet Osteopontin expression in lung cancer Lung Cancer 15 1996 311 323
19. H.W. Pan, Y.H. Ou, and S.Y. Peng Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma Cancer 98 2003 119 127
20. H. Teramoto, M.D. Castellone, and R.L. Malek Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12 Oncogene 24 2005 489 501
21. J.Q. Chen, W.H. Zhan, and Y.L. He Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas World J Gastroenterol 10 2004 776 782
22. G. Gu, J. Yuan, M. Wills, and S. Kasper Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo Cancer Res 67 2007 4807 4815
23. T. Miyoshi, K. Kondo, and N. Hino The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer Clin Cancer Res 3 1997 1289 1297
24. D. Pham, and D.H. Harpole Stage I NSCLC: elucidating the prognostic factors Thorax 64 2009 185 186
25. C.H. Dai, J. Li, and L.C. Yu Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer Tumour Biol 34 2013 1245 1253
26. G. Mohajeri, M.H. Sanei, and S.A. Tabatabaee Micrometastasis in non-small-cell lung cancer: Detection and staging Ann Thorac Med 7 2012 149 152
27. A. Baisi, F. Raveglia, M. De Simone, and U. Cioffi Micrometastasis and skip metastasis as predictive factors in non-small-cell lung cancer staging Eur J Cardiothorac Surg 43 2013 1075
28. A. Hill, S. McFarlane, P.G. Johnston, and D.J. Waugh The emerging role of CD44 in regulating skeletal micrometastasis Cancer Lett 237 2006 1 9
29. L.F. Raheja, D.C. Genetos, and C.E. Yellowley Hypoxic osteocytes recruit human MSCs through an OPN/CD44-mediated pathway Biochem Biophys Res Commun 366 2008 1061 1066